FINHUB Insights

Kenvue Q1 FY26: where the revenue came from and where it went

The whole income statement of Kenvue for this quarter, as one diagram: what earned the revenue, and what it went on.

Period
Dec 29, 2025 – Mar 29, 2026
Reported
May 7, 2026 10-Q accession 0001944048-26-000098

Revenue$3.91B +4% year over year
Gross profit$2.30B 59% margin
Operating profit$0.77B 20% margin
Net profit$0.47B 12% margin
100% free

It's free. All of it.

A free account opens every diagram. We send one link to confirm your address, and that is the whole of it.

Already have an account? Sign in

The numbers

All figures in billions of U.S. dollars, for Q1 FY26 (period ends Mar 29, 2026).
ItemValueShare of revenueYear over year
Revenue 3.91 100% +4%
Self care 1.70 44% +2%
Essential health 1.15 29% +5%
Skin health & beauty 1.06 27% +8%
Cost of revenue−1.6141%
Gross profit2.3059% margin+1pp
R&D−0.082%+0pp
SG&A−1.4537%−4pp
Operating profit0.7720% margin+5pp
Interest & other costs−0.10
Tax−0.20
Net profit0.47 12% margin+4pp

Source of the numbers: structured XBRL data from the filing (10-Q). The diagram is generated automatically and checked against EDGAR before release. How we calculate it → About and methodology.

99 of 418 companies, most recently reported first